ReviewPharmaceuticals (Basel, Switzerland)2025

State-of-the-Art Evidence for Clinical Outcomes and Therapeutic Implications of Janus Kinase Inhibitors in Moderate-to-Severe Ulcerative Colitis: A Narrative Review.

Yunseok Choi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.